精品国产一区二区三区免费,天天操天天日天天吻夜夜吻,亚洲成年人免费网站观看,99部国产精品免费观看

歡迎進(jìn)入上海起發(fā)實(shí)驗試劑有限公司!
產(chǎn)品展示
首頁 > 產(chǎn)品展示 > > Cellular Technology Ltd (CTL) > Cellular Technology Ltd (CTL)公司介紹

Cellular Technology Ltd (CTL)公司介紹

描述:國凱斯西儲大學(xué)(CWRU)的病理學(xué)教授Paul V. Lehmann博士開發(fā)出新一代ELISPOT檢測技術(shù),繼而創(chuàng)立CTL公司,致力于為用戶提供Z精確的ELISPOT檢測儀器和解決方案。

更新時間:2016-12-22
訪問次數(shù):3382
廠商性質(zhì):代理商
詳情介紹

美國Cellular Technology Ltd (CTL)  www.elispot.cn  www.immunospot.com
 Cellular Technology Ltd (CTL)是世界和zui大的 ELISPOT 技術(shù)解決方案提供商。CTL 由 1996 年在美國 Ohio Case Western Reverse University 大學(xué)發(fā)明新一代 ELISPOT 分析方法的 Paul V. Lehmann 教授所創(chuàng)建。
CTL 是 ELISPOT 技術(shù)的世界*,*創(chuàng)立了當(dāng)代新型 ELISPOT 方法,將 ELISPOT 技術(shù)提升到了精確科學(xué)的高度;*將圖像分析引入到 ELISPOT中,制造出世界上*臺商業(yè) ELISPOT 分析儀。CTL 15年來一直從事細(xì)胞免疫學(xué)研究,專注于 ELISPOT 領(lǐng)域已經(jīng)超過 10 年的歷史。CTL 是美國 NIH 免疫耐受網(wǎng)*的 ELISPOT 分析實(shí)驗室和分析儀提供商。CTL 提供 ELISPOT 分析儀硬件、軟件和相關(guān)服務(wù)。是世界上*能提供 ELISPOT 服務(wù),包括雙色分析、質(zhì)量控制和大規(guī)模 ELISPOT 協(xié)約服務(wù)在內(nèi)的技術(shù)提供商。敬請,探討 ELISPOT 技術(shù)如何為您的科研、臨床和新藥研制等領(lǐng)域提供有力的幫助。
Cellular Technology Ltd. was formed in 1998 by Dr. Paul V. Lehmann, a Professor at the Case Western Reserve University School of Medicine. 

Dr. Lehmann is a leader in the field of T cell immunology with over 20 high ranking publications dedicated to establishing the scientific basis of cytokine ELISPOT analysis.

Dr. Lehmann developed the original ImmunoSpot technology in order to conduct his own research more effectively. The ImmunoSpot platform is the most frequently referenced in the scientific literature in this field and is widely accepted to be the gold standard. Applications of ImmunoSpot technology include diagnosis and drug discovery for infectious diseases such as HIV and tuberculosis, better understanding and treatment of allergies and autoimmunity, the ability to predict rejection/acceptance responses in organ transplantation and significant improvements in vaccine development and monitoring including for various cancers where post treatment monitoring will be a key part of the therapy.

Dr. Lehmann pioneered the development of tools to accuray and reproducibly measure T cell responses. Dr. Lehmann and CTL designed and constructed the world’s very first ELISPOT reader under US Patent No: 6,410,252 (Methods for Measuring T Cell Cytokines, issued June 25, 2002). The company has been at the forefront of this field ever since.

In 2001, CTL established a laboratory to provide assay services to companies and academic researchers involved in cellular immunology research, drug discovery and drug development. These services include immunogenicity testing, plate scanning and analysis, and ELISPOT assay training.

Within recent years, CTL has expanded its platform to include additional products and services for those in the scientific community. These include cryopreserved PBMC, serum-free media, plaque and colony counters, and expanded contract research services.

Headquartered in Cleveland, Ohio, CTL has expanded to include offices in China, Germany, and Japan.


 CTL has been recognized as the leader in basic science publications about (and clinical application of) ELISPOT assays, instrumentation, software, and reagent solutions. CTL is the only entity that specializes in developing ELISPOT instrumentation, assays, and their implementation in GLP compliant contract research. As such, CTL has been recognized by the Cancer Vaccine Consortium as the ELISPOT reference laboratory and has been awarded by the U.S. National Institutes of Health (NIH) a contract for the validation of the ELISPOT assay for clinical trials.

In recent years, CTL has expanded to include instrumentation for evaluating bioassays as well as reagent solutions including cryopreserved PBMC samples and serum-free media.

Because of its commitment to world-class quality and performance, CTL was awarded the 2005 “Excellence in Exporting” award by the State of Ohio’s Governor’s Office.

Today, CTL’s instrumentation and products are placed in over 30 countries, with over 350 institutes adopting the ImmunoSpot® platform for their immunological research needs.

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
男生的鸡巴插进女生的逼| 亚洲综合av毛片手机版| 约炮大屌黑人的金发美妇| 国产乱码一二三区别在哪| 欧美性极品xxxx娇小| 久久99热只有频精品66| 国产日韩精品欧美一区喷| 蜜臀一区二区三区精品无卡| 欧美成人精品资源在线观看| 一本久道久久综合狠狠躁| 日韩精品国产一区二区在线| 日韩性生活视频在线观看| 青娱乐91亚洲| 国产第一页免费浮力影院| 国产肏女人视频| 26UUU亚洲| 性爱天天日天天干天天操| 亚洲精品成年人免费网站| 日韩亚洲欧美一区二区三区| 国产精品日韩欧美在线观看| 91欧美一区二区三区人| 久久精品色欧美一区二区| 亚洲性无码一区二区三区| 男女互操www| 午夜亚洲Av无码高潮片| 亚洲一级毛片无码无遮挡| 男人的j桶女人免费网站| 男人狂操女人下部小视频| 高清女厕偷拍一区二区三| 欧美在线一区二区三区观看| 操骚逼手机视频| 被叼着奶头吃奶水的美女| 国产福利高颜值在线观看| 欧美一级特黄大片做受多人| 疯狂揉小核到失禁喷水h| 大阴茎后入出水骚肛视频| 粗长顶弄1v1娇柔多汁| 日韩中文字幕电影一二三区| 欧美xxxbbb在线视频| 她也操在线视频| 69堂成人精品免费视频|